SMS Lifesciences India Limited
NSE: SMSLIFE BSE: 540679 SECTOR: Healthcare - Pharmaceuticals & Biotechnology
1393 39(3%)
Volume
-
Open
0
High
0
Low
0
Close
1,354
VWAP
0
52 Week High
1,680
52 Week Low
960
Quality Score
00/00
Growth Score
00/00
Valuation Score
00/00
Momentum Score
00/00
Analyst Recommendations
BUY/SELL
|
|
Analyst Price Target
-
Market Cap (cr)
421
No. of Shares
P/E
17.03
P/B
2.1
Face Value
10
Div. Yield
-
Book Value (TTM)
-
CASH
-
DEBT
-
EPS (TTM)
-
ROE
12.32
ROCE
-
Profit Growth
-
Listing Date
17-Aug-17
Promoter Holding
71.79%
FII Holding
-
DII Holding
0.29%
Price Chart
Price Performance
1 Week0
1 Month0
3 Months0
6 Months0
1 Year0
YTD0
Moving Average
5 Day SMA0
10 Day SMA0
20 Day SMA0
30 Day SMA0
50 Day SMA0
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
| Standard | Camarilla | Fibonacci | Woodie's | |
|---|---|---|---|---|
| Resistance 3 | ||||
| Resistance 2 | ||||
| Resistance 1 | ||||
| Pivot Point | ||||
| Support 1 | ||||
| Support 2 | ||||
| Support 3 |
Competitors/Peers
| # | Symbol | MCAP | LTP | 1W | 1M | 6M | 1Y | P/E | Ind PE | Debt/Eq | Div Yld % | NP Qtr Rs.Cr. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | 4,42,187 | 1843 | 2% | 14% | 2% | 9% | 39 | 0 | 0 | 0 | |
| 2 | DIVISLAB | 1,80,280 | 6791 | 2% | 6% | 4% | 1% | 65 | 0 | 0 | 0 | |
| 3 | TORNTPHARM | 1,53,281 | 4529 | 0% | 8% | 18% | 40% | 64 | 0 | 0 | 0 | |
| 4 | APOLLOHOSP | 1,19,047 | 8280 | 3% | 7% | 12% | 17% | 58 | 0 | 0 | 0 | |
| 5 | CIPLA | 1,14,869 | 1422 | 1% | 10% | 7% | 4% | 22 | 0 | 0 | 0 | |
| 6 | DRREDDY | 1,11,015 | 1330 | 0% | 1% | 7% | 7% | 20 | 0 | 0 | 0 | |
| 7 | ZYDUSLIFE | 1,09,378 | 1087 | 6% | 16% | 15% | 17% | 20 | 0 | 0 | 0 | |
| 8 | LUPIN | 1,04,017 | 2275 | 1% | 2% | 9% | 15% | 23 | 0 | 0 | 0 | |
| 9 | MANKIND | 1,00,482 | 2434 | 3% | 7% | 7% | 2% | 49 | 0 | 0 | 0 | |
| 10 | MAXHEALTH | 96,867 | 995 | 7% | 1% | 15% | 14% | 0 | 0 | 0 | 0 | |
| Load More | ||||||||||||
Quarterly Results
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.78 | 81.37 | 82.5 | 89.11 | 84.6 | 78.46 | 92.55 | 89.99 | 72.05 | 69.26 | 74.65 | 63.73 | 88.29 | 81.26 | 82.28 | 95.66 | 91.06 | 86.75 | 76.27 |
| Expenses | 80.73 | 67.79 | 70.79 | 81.69 | 71.85 | 69.89 | 76.27 | 78.63 | 62.75 | 61.33 | 72.11 | 61.45 | 78.92 | 72.99 | 73.79 | 89.23 | 82.59 | 77.13 | 68.06 |
| Operating Profit | 14.05 | 13.58 | 11.71 | 7.42 | 12.75 | 8.57 | 16.28 | 11.36 | 9.3 | 7.93 | 2.54 | 2.28 | 9.37 | 8.27 | 8.49 | 6.43 | 8.47 | 9.62 | 8.21 |
| OPM % | 14.82 | 16.69 | 14.19 | 8.33 | 15.07 | 10.92 | 17.59 | 12.62 | 12.91 | 11.45 | 3.4 | 3.58 | 10.61 | 10.18 | 10.32 | 6.72 | 9.3 | 11.09 | 10.76 |
| Other Income | 0.18 | 0.42 | 1 | 2.34 | 0.06 | 2.04 | 0.44 | 2.36 | 0.58 | 0.27 | 0.61 | 4.81 | 0.49 | 0.15 | 0.31 | 6.64 | 0.03 | 8.44 | 0.07 |
| Interest | 1.54 | 1.62 | 1.87 | 2.03 | 2.14 | 2.14 | 2.4 | 2.84 | 2.34 | 2.81 | 2.18 | 1.8 | 1.67 | 1.68 | 1.64 | 1.75 | 1.49 | 1.82 | 1.12 |
| Depreciation | 3.91 | 3.89 | 3.82 | 3.8 | 3.76 | 3.76 | 3.68 | 3.78 | 3.73 | 3.73 | 3.7 | 2.92 | 2.63 | 2.64 | 2.59 | 2.58 | 2.61 | 2.69 | 2.13 |
| Profit before tax | 8.78 | 8.49 | 7.02 | 3.93 | 6.91 | 4.71 | 10.64 | 7.1 | 3.81 | 1.66 | -2.73 | 2.37 | 5.56 | 4.1 | 4.57 | 8.74 | 4.4 | 13.55 | 5.03 |
| Tax % | 24.26 | 24.38 | 37.61 | 11.45 | 29.81 | 29.72 | 33.27 | 8.73 | -8.14 | 126.51 | 40.29 | 10.55 | 31.29 | 23.66 | 49.23 | 7.67 | 46.82 | 24.28 | 27.83 |
| Net Profit | 6.65 | 6.42 | 4.39 | 3.48 | 4.86 | 3.3 | 7.1 | 6.47 | 4.12 | -0.44 | -3.83 | 2.11 | 3.82 | 3.12 | 2.32 | 8.08 | 2.33 | 10.25 | 3.63 |
| EPS in Rs | 21.9 | 20.18 | 13.76 | 9.82 | 18.09 | 15.45 | 23.15 | 19.52 | 14.22 | 2.25 | -5.95 | 5.66 | 13.2 | 9.1 | 9.96 | 26.79 | 7.71 | 33.9 | 12.01 |
Profit and Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|---|
| Sales | 345 | 306 | 316 | 350 | 266 | 261 | 378 |
| Expenses | 300 | 275 | 287 | 316 | 235 | 235 | 343 |
| Operating Profit | 45 | 31 | 29 | 35 | 30 | 25 | 35 |
| OPM % | 13 | 10 | 9 | 10 | 11 | 10 | 9 |
| Other Income | 5 | 4 | 5 | 14 | 2 | 2 | 2 |
| Interest | 9 | 10 | 7 | 6 | 5 | 5 | 6 |
| Depreciation | 15 | 15 | 11 | 10 | 8 | 8 | 6 |
| Profit before tax | 26 | 10 | 17 | 33 | 20 | 15 | 25 |
| Tax % | 28 | 36 | 31 | 23 | 31 | 31 | 30 |
| Net Profit | 19 | 6 | 11 | 25 | 14 | 10 | 18 |
| EPS in Rs | 66.52 | 30.07 | 37.91 | 83.75 | 44.85 | 33.67 | 59.04 |
| Dividend Payout % | 2 | 5 | 4 | 2 | 3 | 0 | 3 |
Cash Flows
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 34 | 24 | 15 | -11 | 35 | 15 | 30 |
| Cash from Investing Activity | -15 | -18 | -31 | -7 | -26 | -27 | -44 |
| Cash from Financing Activity | -19 | -7 | 17 | 11 | -3 | 12 | 15 |
| Net Cash Flow | 0 | -1 | 0 | -8 | 6 | 0 | 1 |
Balance Sheet
| Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 203 | 194 | 185 | 174 | 166 | 149 | 126 | 113 | 103 |
| Borrowings | 70 | 86 | 92 | 101 | 100 | 80 | 65 | 65 | 47 |
| Other Liabilities | 118 | 107 | 111 | 114 | 126 | 125 | 108 | 72 | 116 |
| Total Liabilities | 394 | 390 | 391 | 391 | 395 | 357 | 302 | 253 | 270 |
| Fixed Assets | 226 | 232 | 217 | 223 | 228 | 142 | 130 | 124 | 118 |
| CWIP | 9 | 0 | 13 | 6 | 1 | 51 | 38 | 16 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 159 | 158 | 161 | 162 | 166 | 164 | 134 | 113 | 148 |
| Total Assets | 394 | 390 | 391 | 391 | 395 | 357 | 302 | 253 | 270 |
Delivery
Daily Market Cap
No records found.
Stock Checklist
Price is above from 52 week high low average: 20%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: YES